Ou, S.-H.I.
University of California, Irvine · UC Irvine Chao Family Comprehensive Cancer Center
2 papers on CoChatORCID 0000-0002-4138-8465
Most cited papers
- Verified
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001
Shaw, A. T., Riely, G. J., Bang, Y.-J., Kim, D.-W., Camidge, D. R., Solomon, B. J., Varella-Garcia, M., Iafrate, A. J., Shapiro, G. I., Usari, T., et al. (2019) · Annals of Oncology
Lung Cancer Treatments and MutationsLung Cancer Research Studies
Cited by 576
- Verified
KRYSTAL-1: Activity and Safety of Adagrasib (MRTX849) in Advanced/ Metastatic Non–Small-Cell Lung Cancer (NSCLC) Harboring KRAS G12C Mutation
Jänne, P. A., Rybkin, I. I., Spira, A. I., Riely, G. J., Papadopoulos, K. P., Sabari, J. K., Johnson, M. L., Heist, R. S., Bazhenova, L., Barve, M., et al. (2020) · European Journal of Cancer
Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling
Cited by 140
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free